| 000 | 01791 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518091240.0 | ||
| 264 | 0 | _c20210713 | |
| 008 | 202107s 0 0 eng d | ||
| 022 | _a1872-9711 | ||
| 024 | 7 |
_a10.1016/j.neuro.2020.03.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChaturvedi, Swati | |
| 245 | 0 | 0 |
_aMechanistic exploration of quercetin against metronidazole induced neurotoxicity in rats: Possible role of nitric oxide isoforms and inflammatory cytokines. _h[electronic resource] |
| 260 |
_bNeurotoxicology _c07 2020 |
||
| 300 |
_a1-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xmetabolism |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetronidazole |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aNeurotoxicity Syndromes _xetiology |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xmetabolism |
| 650 | 0 | 4 |
_aQuercetin _xpharmacology |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSignal Transduction |
| 700 | 1 | _aMalik, Mohd Yaseen | |
| 700 | 1 | _aRashid, Mamunur | |
| 700 | 1 | _aSingh, Sandeep | |
| 700 | 1 | _aTiwari, Virendra | |
| 700 | 1 | _aGupta, Parul | |
| 700 | 1 | _aShukla, Shubha | |
| 700 | 1 | _aSingh, Sarika | |
| 700 | 1 | _aWahajuddin, Muhammad | |
| 773 | 0 |
_tNeurotoxicology _gvol. 79 _gp. 1-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuro.2020.03.002 _zAvailable from publisher's website |
| 999 |
_c30722146 _d30722146 |
||